Beijing, China

Xiangli Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Creative Trio Biotech (Beijing) Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangli Zhang. Retrieved from https://idiyas.com/inventor/xiangli-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiangli Zhang: Innovator in Antibacterial Polypeptide Medicine

Introduction

Xiangli Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial polypeptide medicines. His innovative approach has the potential to impact healthcare positively.

Latest Patents

Xiangli Zhang holds a patent for the "Preparation method of new recombinant antibacterial polypeptide medicine." This invention provides a method for preparing a new recombinant antibacterial polypeptide medicine. It primarily relates to a liquid culture medium formula suitable for large-scale production of the antibacterial polypeptide, as well as the optimization of enlarged culture parameters. He has 1 patent to his name.

Career Highlights

Xiangli Zhang is associated with Creative Trio Biotech (Beijing) Co., Ltd. His work at this company has allowed him to focus on innovative solutions in biotechnology. His expertise in the field has positioned him as a valuable asset in the development of new medical treatments.

Collaborations

Xiangli Zhang has collaborated with notable colleagues, including Xiaoqing Qiu and Rongqi Li. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Xiangli Zhang is a dedicated inventor whose work in antibacterial polypeptide medicine showcases his commitment to advancing healthcare through innovation. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…